MedPath

NYULMC CareSmarts Pilot

Not Applicable
Completed
Conditions
Type 2 Diabetes (T2D)
Diabetes
Interventions
Behavioral: Standard of Care Reminders and Self Assessments
Behavioral: CareSmarts Mobile Health Diabetes Program
Registration Number
NCT02726217
Lead Sponsor
NYU Langone Health
Brief Summary

CareSmarts is a theory-driven behavioral intervention designed to improve self-care among patients with Type 2 diabetes (T2D) with poor glycemic control (HbA1c\>8%), through multiple mediators, including cuing, education, self-efficacy, social support, and health beliefs. Individuals will be randomly assigned with equal allocation to either the CareSmarts intervention or to usual care for 6 months.

Detailed Description

CareSmarts is a mobile diabetes program that provides self-management support and team-based care management for people with diabetes through automated SMS messages. The program is a theory-driven behavioral intervention designed to improve self-care through multiple mediators, including cuing, education, self-efficacy, social support, and health beliefs. Participants in the program receive educational and motivational text messages about diabetes self-care, some prompts to engage in a particular action (for example, "Time to check your blood sugar"), and some self-assessment questions (such as, "Do you need refills of any of your medications?") to which the patient responds by texting. Participants' responses to self-assessment questions are used to facilitate remote monitoring and care management by the health care team. A response that is outside established parameters triggers an alert. Using protocols, nurses respond to each alert by the next business day.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
26
Inclusion Criteria
  • have a DRG Code of T2D, and be prescribed at least one oral T2D drug and/or insulin.
  • must own an SMS capable mobile device and be willing to send and receive SMS messages regarding T2D self-management.
  • The participant's physician of record will have verified that his/her patient can safely participant in an intervention study that targets an HbA1c <7%.
Exclusion Criteria
  • unable or unwilling to provide informed consent
  • unable to participate meaningfully in an intervention that involves use of SMS messages (e.g., due to uncorrected sight impairment, illiterate, non-English-speaking)
  • unwilling to accept randomization assignment
  • pregnant, plans to become pregnant in the next 6 months, or who become pregnant during the study
  • gestational diabetes
  • breastfeedling
  • individuals who are institutionalized (e.g., in a nursing home or personal care facility, or those who are incarcerated and have limited control over self-management)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlStandard of Care Reminders and Self AssessmentsStandard of Care reminders and assessments for individuals with Diabetes
CareSmarts InterventionStandard of Care Reminders and Self AssessmentsParticipants in the program receive text messages about diabetes self-care
CareSmarts InterventionCareSmarts Mobile Health Diabetes ProgramParticipants in the program receive text messages about diabetes self-care
Primary Outcome Measures
NameTimeMethod
Satisfaction with Care measured by Diabetes Treatment Satisfaction Questionnaire (DTSQ).3 Months
Adherence to the diabetes self-management regimen using the Diabetes Self Management Questionnaire (DSMQ).3 Months
Acceptability of the intervention protocol will be evaluated using a satisfaction survey.3 Months
Measure of glucose3 Months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

New York University School of Medicine

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath